Core Insights - Nvidia remains a dominant player in the AI chip market, with significant demand from major customers like Amazon, Microsoft, Google, and Meta [1] - Oracle is emerging as a serious contender in the AI space, evidenced by a 36% stock surge following strong cloud demand numbers [2] - Oracle reported $332 billion in bookings for its latest quarter, marking a significant shift towards becoming a Data Center Operator, despite missing revenue and earnings estimates [3] - The company signed four multibillion-dollar contracts, leading to a 359% year-over-year increase in remaining performance obligations [4] - Oracle's management anticipates a substantial increase in Cloud Infrastructure revenue, projecting growth from $18 billion in FY26 to $114 billion in FY29 [5]

Core Insights - Absci Inc. has partnered with Oracle Corporation and AMD to enhance its generative AI-driven drug discovery capabilities [1][2] - The collaboration aims to streamline infrastructure and accelerate biologics design cycles through advanced AI technologies [1][2] Group 1: Collaboration and Technology - Absci's generative AI Drug Creation Platform utilizes Oracle Cloud Infrastructure (OCI) and AMD's hardware to improve drug discovery processes [1] - The partnership allows for large-scale molecular-dynamics simulations and comprehensive antibody design, significantly speeding up development and operations [2] Group 2: Infrastructure and Performance - The integration of fifth-generation AMD EPYC processors and RDMA cluster networking in OCI's bare metal instances provides the necessary low-latency networking and throughput for extensive model training [3] - Direct access to AMD GPUs in a flat-network supercluster has minimized hypervisor overhead and reduced inter-GPU latency to as low as 2.5 microseconds, enhancing data streaming capabilities [4] Group 3: Market Reaction - Following the announcement, Absci's stock price increased by 10.50%, reaching $2.63 [5]

Core Insights - E-commerce spending in the U.S. increased by 8% year-over-year in August, up from 7% growth in July, indicating a positive outlook for Amazon and other e-commerce stocks [2] - Amazon's North America Retail growth is forecasted at 10% year-over-year for Q3, slightly down from 11% in Q2, but current data suggests it may exceed expectations [3][5] - The penetration of online spending reached 28.2% of all comparable U.S. retail purchases, an increase from 26.6% the previous month, highlighting the growing shift towards e-commerce [3] Economic Context - The consumer price index rose by 0.4% in August, slightly higher than expected, which may be influencing consumer behavior towards online shopping due to price comparisons [4] - Tariffs on imports are likely driving more customers to shop online, benefiting Amazon's competitive position [4] Stock Performance - Amazon's stock was trading around $231.10, showing fluctuations near its 21-day moving average, with a recent brief breakout above a flat base buy point of $236.53 [6] - Year-to-date, Amazon's stock has gained 5%, underperforming the S&P 500, partly due to concerns over tariffs affecting prices on imported goods [7] Competitive Landscape - Amazon faces competition in the cloud sector from Microsoft and Alphabet, with Oracle reporting significant growth in cloud contracts, indicating a competitive environment [8]

Core Insights - Leidos Holdings, Inc. has been recognized as one of the 10 Best Space Exploration Stocks to Buy Now, highlighting its strong position in the industry [1] - The company has achieved Amazon Web Services' Trusted Secure Enclave Vetted Partner certification, underscoring its commitment to secure cloud architecture [1][2] - Leidos supports AUKUS Pillar 2, emphasizing the importance of secure cooperation among allies in defense and research [3] Company Performance - Leidos Holdings, Inc. reported $16.7 billion in revenue for FY2024, indicating robust financial performance [3] - The company employs approximately 47,000 individuals globally, reflecting its significant operational scale [3] Industry Position - Leidos is ranked fifth among the Best Space Stocks, showcasing its competitive standing in the space exploration sector [3]

BREAKING: Core CPI Steady, Jobless Claims Highest Since Oct. 2021 One of the easiest ways to find stock market leaders is to use the Relative Strength At New Highs screen in the IBD Screener. This exclusive IBD screen focuses on ideas with market-beating performance, which can be some of the biggest winners in the continuing uptrend in stocks. IBD readers can easily discern those stock market-beating performers, using the IBD… AI Stocks Face 'Show Me' Test. Why Revenue Rules Matter Amid Oracle, Cloud Rally ...

Core Viewpoint - Alibaba's Q2 2025 financial report shows a lower-than-expected decline in operating profit, an increase in cloud business revenue growth, and a rebound in cash reserves after five consecutive quarters of decline, leading to a more than 20% rise in its stock price since the report's release [4][5][6]. Financial Performance - In Q2 2025, Alibaba's cash reserves reached approximately 183.1 billion yuan, an increase of 37.6 billion yuan from the previous quarter, marking the first rebound after five quarters of decline [6]. - The company reported a net cash outflow of 18.8 billion yuan in free cash flow for the quarter, the first negative figure in three years, prompting a need for increased liquidity [11][12]. Strategic Adjustments - Alibaba's strategy shifted in 2025, with a focus on a 380 billion yuan capital expenditure plan for AI and cloud services, alongside a commitment to instant retail, leading to increased cash requirements [11][20]. - The company reduced its stock buyback amount significantly from approximately 42.7 billion yuan in Q2 2024 to about 5.84 billion yuan in Q2 2025, indicating a strategic pivot towards maintaining liquidity [12][19]. Asset Management - Alibaba's short-term investments totaled 191.7 billion yuan in Q2 2025, a decrease of 37.1 billion yuan from the previous quarter, contributing to the increase in cash reserves [15]. - The company has been actively selling off non-core assets, including shares in various companies, to bolster cash reserves, with total cash generated from these sales estimated at 2 to 3 billion yuan [17][18]. Market Positioning - The increase in cash reserves is seen as a preparation for significant capital expenditures and a signal of Alibaba's commitment to expanding its cloud and AI capabilities [20][22]. - By streamlining its operations and focusing on core businesses, Alibaba aims to enhance its valuation, moving away from a "large and comprehensive" model to a "strong and precise" approach [24]. Valuation Outlook - Alibaba's strategic focus on AI and cloud services, coupled with a reduction in non-core investments, positions the company to potentially align its valuation with leading domestic and international peers in the cloud and AI sectors [25][27].

Core Idea - Shares of Cloud computing platform CoreWeave, Inc. (NASDAQ: CRWV) increased by 17% following the announcement of the establishment of its own venture capital arm aimed at investing in promising start-ups utilizing artificial intelligence [1] Company Developments - CoreWeave, Inc. is initiating a venture capital arm to focus on investments in start-ups that leverage artificial intelligence technologies [1] - The announcement has positively impacted the stock price, reflecting investor confidence in the company's strategic direction [1] Market Reaction - The stock price surge of 17% indicates strong market interest and optimism regarding CoreWeave's new investment strategy [1] - This move may position CoreWeave as a significant player in the AI investment landscape, potentially attracting further investor attention [1]

Core Viewpoint - Oracle's stock is experiencing an upward trend as the market reacts positively to its growth in cloud computing, with future success heavily reliant on advancements from OpenAI [1] Company Summary - Oracle's stock performance is linked to its cloud-computing surge, indicating strong market interest and potential for growth [1] - The company's future trajectory is closely tied to developments in artificial intelligence, particularly those driven by OpenAI [1] Industry Summary - The cloud computing sector is witnessing significant growth, with companies like Oracle benefiting from increased market demand [1] - The integration of AI technologies, such as those from OpenAI, is becoming a critical factor for success in the cloud computing industry [1]

AI stocks 2025: While tech giants like Nvidia and Palantir Technologies continue to make headlines in the booming artificial intelligence (AI) industry, a much smaller player has quietly outperformed them both in 2025 and by a wide margin.Nebius Group Stock Surges 136% in 2025, Beating Nvidia and PalantirNebius Group (NASDAQ: NBIS), a Dutch company focused on AI-driven data centers, has seen its stock soar 136% so far this year, as per a report. That’s well ahead of Nvidia’s 24% gain and Palantir’s 102% ris ...

Core Insights - Absci collaborates with Oracle Cloud Infrastructure (OCI) and AMD to enhance its generative AI-driven drug discovery platform, aiming to accelerate biologics design cycles and reduce costs [1][2][3] Company Overview - Absci is a clinical-stage biotech company focused on advancing novel therapeutics using generative AI, with a mission to create better biologics for patients more quickly [5] - The company utilizes an Integrated Drug Creation™ platform that combines advanced AI models with a synthetic biology data engine, facilitating rapid design and validation of therapeutics [5] Technology and Infrastructure - Absci has selected OCI as the technical foundation for developing AI models and scaling AI workflows, enabling large-scale molecular-dynamics simulations and end-to-end antibody design [2][3] - The collaboration leverages OCI's bare metal instances powered by 5th Generation AMD EPYC™ processors and ultrafast RDMA networking, providing low-latency networking and high throughput for model training and simulations [3][4] - The integration of AMD's next-generation Instinct™ MI355X GPUs further enhances the performance and scalability of Absci's AI Drug Creation Platform [2][4] Industry Impact - The partnership between Absci, OCI, and AMD exemplifies how AI can transform drug discovery processes, accelerating the development of novel therapeutics [4] - The collaboration aims to push the boundaries of biologics design by combining cutting-edge AI models with high-performance infrastructure [3][4]